Iihara H[au] - Search Results

Year	Number of Results
1982	2
1983	1
2005	1
2006	2
2007	5
2008	1
2009	2
2010	2
2011	2
2012	3
2013	3
2015	5
2016	8
2017	4
2018	2
2019	11
2020	12
2021	12
2022	0

1

Association of albumin-bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenib.

Watanabe D, Fujii H, Yamada Y, Matsuhashi N, Makiyama A, Iihara H, Takahashi T, Kiyama S, Kobayashi R, Yoshida K, Suzuki A. Watanabe D, et al. Among authors: iihara h. Int J Clin Oncol. 2021 Jul;26(7):1257-1263. doi: 10.1007/s10147-021-01910-2. Epub 2021 Apr 11. Int J Clin Oncol. 2021. PMID: 33839963

2

Primary Prophylaxis of Febrile Neutropenia With Pegfilgrastim in Small-cell Lung Cancer Patients Receiving Amrubicin as Second-line Therapy.

Sato Y, Iihara H, Kinomura M, Hirose C, Fujii H, Endo J, Yanase K, Kaito D, Sasaki Y, Gomyo T, Sakai C, Iwai M, Tsuboi Y, Ishihara T, Kobayashi R, Ohno Y, Suzuki A. Sato Y, et al. Among authors: iihara h. Anticancer Res. 2021 Mar;41(3):1615-1620. doi: 10.21873/anticanres.14923. Anticancer Res. 2021. PMID: 33788757

3

5HT₃ RA plus dexamethasone plus aprepitant for controlling delayed chemotherapy-induced nausea and vomiting in colorectal cancer.

Hayashi T, Shimokawa M, Matsuo K, Nishimura J, Iihara H, Nakano T, Egawa T. Hayashi T, et al. Among authors: iihara h. Cancer Sci. 2021 Feb;112(2):744-750. doi: 10.1111/cas.14757. Epub 2020 Dec 17. Cancer Sci. 2021. PMID: 33274555 Free PMC article. Clinical Trial.

4

Evaluation of clinical pharmacist interventions for adverse events in hospitalized patients with thoracic cancer receiving cancer chemotherapy.

Iihara H, Hirose C, Funaguchi N, Endo J, Ito F, Yanase K, Kaito D, Ohno Y, Suzuki A. Iihara H, et al. Mol Clin Oncol. 2021 Jun;14(6):116. doi: 10.3892/mco.2021.2278. Epub 2021 Apr 8. Mol Clin Oncol. 2021. PMID: 33903822 Free PMC article.

5

Impact of Anti-angiogenic Agents on Chemotherapy Efficacy in Patients With Metastatic Colorectal Cancer: Second-line FOLFIRI Plus Bevacizumab or Aflibercept.

Yamada Y, Matsuhashi N, Fujii H, Makiyama A, Iihara H, Takahashi T, Watanabe D, Kiyama S, Kobayashi R, Suzuki A, Yoshida K. Yamada Y, et al. Among authors: iihara h. Anticancer Res. 2021 Jan;41(1):533-541. doi: 10.21873/anticanres.14805. Anticancer Res. 2021. PMID: 33419853

6

Dose Adjustment of Oxaliplatin Based on Renal Function in Patients With Metastatic Colorectal Cancer.

Watanabe D, Fujii H, Matsuhashi N, Iihara H, Yamada Y, Ishihara T, Takahashi T, Yoshida K, Suzuki A. Watanabe D, et al. Among authors: iihara h. Anticancer Res. 2020 Apr;40(4):2379-2386. doi: 10.21873/anticanres.14207. Anticancer Res. 2020. PMID: 32234941

7

Low-Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin-Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial.

Sakai C, Shimokawa M, Iihara H, Fujita Y, Ikemura S, Hirose C, Kotake M, Funaguchi N, Gomyo T, Imai H, Hakamata J, Kaito D, Minato K, Arai T, Kawazoe H, Suzuki A, Ohno Y, Okura H. Sakai C, et al. Among authors: iihara h. Oncologist. 2021 Jun;26(6):e1066-e1072. doi: 10.1002/onco.13772. Epub 2021 May 4. Oncologist. 2021. PMID: 33811782 Free PMC article. Clinical Trial.

8

A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic oncology research group 1632.

Noro R, Igawa S, Bessho A, Hirose T, Shimokawa T, Nakashima M, Minato K, Seki N, Tokito T, Harada T, Sasada S, Miyamoto S, Tanaka Y, Furuya N, Kaburagi T, Hayashi H, Iihara H, Okamoto H, Kubota K. Noro R, et al. Among authors: iihara h. Lung Cancer. 2021 Nov;161:49-54. doi: 10.1016/j.lungcan.2021.08.007. Epub 2021 Aug 31. Lung Cancer. 2021. PMID: 34536731 Clinical Trial.

9

Comparison of Chemotherapy-induced Nausea and Vomiting Between Gemcitabine Plus Nab-paclitaxel Combination Chemotherapy and Gemcitabine Monotherapy in Patients With Advanced Pancreatic Cancer.

Ohata K, Fujii H, Sadaka S, Kato-Hayashi H, Iihara H, Kobayashi R, Uemura S, Iwashita T, Shimizu M, Suzuki A. Ohata K, et al. Among authors: iihara h. Anticancer Res. 2021 Jul;41(7):3643-3648. doi: 10.21873/anticanres.15154. Anticancer Res. 2021. PMID: 34230162

10

Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis.

Aogi K, Takeuchi H, Saeki T, Aiba K, Tamura K, Iino K, Imamura CK, Okita K, Kagami Y, Tanaka R, Nakagawa K, Fujii H, Boku N, Wada M, Akechi T, Iihara H, Ohtani S, Okuyama A, Ozawa K, Kim YI, Sasaki H, Shima Y, Takeda M, Nagasaki E, Nishidate T, Higashi T, Hirata K. Aogi K, et al. Among authors: iihara h. Int J Clin Oncol. 2021 Jan;26(1):1-17. doi: 10.1007/s10147-020-01818-3. Epub 2020 Nov 8. Int J Clin Oncol. 2021. PMID: 33161452 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results